AP NEWS

Chronic Myeloid Leukemia: Europe Market & Competitive Landscape - 2018 - ResearchAndMarkets.com

December 5, 2018

DUBLIN--(BUSINESS WIRE)--Dec 5, 2018--The “Europe Chronic Myeloid Leukemia Market and Competitive Landscape - 2018” report has been added to ResearchAndMarkets.com’s offering.

This report provides comprehensive insights into Chronic Myeloid Leukemia pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares.

This study accurately estimates and forecast Chronic Myeloid Leukemia market size and drug sales. This research also provides insights into Chronic Myeloid Leukemia epidemiology and late stage pipeline.

The research is classified into following sections - Chronic Myeloid Leukemia overview with definitions, symptoms, etiology, diagnosis, treatment options; Chronic Myeloid Leukemia pipeline insights covering late stage clinical trials pipeline; Chronic Myeloid Leukemia prevalence trends by countries; Chronic Myeloid Leukemia market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes EU5 countries - Germany, France, Italy, Spain, UK, Europe.

Key Topics Covered

1. Chronic Myeloid Leukemia: Disease Overview

2. Chronic Myeloid Leukemia Pipeline Insights

3. Chronic Myeloid Leukemia Epidemiology Analysis

4. Germany Chronic Myeloid Leukemia Market Insights

5. France Chronic Myeloid Leukemia Market Insights

6. Italy Chronic Myeloid Leukemia Market Insights

7. Spain Chronic Myeloid Leukemia Market Insights

8. UK Chronic Myeloid Leukemia Market Insights

9. Europe Chronic Myeloid Leukemia Market Insights

10. Research Methodology

For more information about this report visit https://www.researchandmarkets.com/research/xn4s8f/chronic_myeloid?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181205005355/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Leukemia Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH ONCOLOGY PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 12/05/2018 07:08 AM/DISC: 12/05/2018 07:08 AM

http://www.businesswire.com/news/home/20181205005355/en

AP RADIO
Update hourly